Fiocruz News
Most Popular Fiocruz Story
Fiocruz granted royalty-bearing license from iBio
IBio, which focuses on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases, has granted a commercial, royalty-bearing Read more...
Latest Headlines
- January 19, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
